ReAble Therapeutics Inactive 10-Q2006 Q1 Quarterly report

Filed: 10 May 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: adversely, advisory, amendment, announcement, APIC, arrangement, award, begun, behavior, budget, carefully, catalogue, chiropractic, Classification, clearance, comparison, Compex, consumer, contrast, converge, curve, detailed, devote, directly, discrete, dispute, EITF, electrical, employ, employment, enhanced, evidence, facing, FAS, FSP, handling, immaterial, implementation, implied, incentive, incremental, intrinsic, January, joined, key, larger, low, motion, Nasdaq, National, noncash, Nonqualified, nonvested, obsolete, owed, panel, par, paragraph, passive, persuasive, plan, pool, post, projected, prospective, Provision, purport, ratably, reclassification, recovery, regularly, regulatory, requisite, retired, retirement, scheduled, serve, serving, set, shelf, shipment, stimulation, successful, surgeon, tailored, Treasury, unrecognized, unvested, volatility, wasted, write, yield

Removed: abnormal, accounted, alternative, apply, attain, carry, Chapter, charged, commission, core, delayed, depreciated, develop, dollar, double, dysphagia, earned, entered, excessive, exist, experienced, expiration, extensive, fewer, funding, greater, hardware, IHC, improve, improved, instrument, Intelect, invest, laser, longer, machine, manner, manufacture, meaningful, milestone, monitor, omitted, operation, outlined, prepaid, prime, privately, public, question, quoted, realization, realized, reconstruction, rehandling, secured, shared, Similarly, software, stockholder, support, taxable, translate, ultrasound, unsecured, usage, utilize, utilized, Vectra, XT

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ReAble Therapeutics similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of Periodic Financial Report
Pursuant to 18 U.S.C. Section 1350

For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Kenneth W. Davidson, the chief executive officer of Encore Medical Corporation (the “Company”) hereby certifies that:

(i) This Quarterly Report on Form 10-Q for the quarter ended April 1, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2006


/s/ Kenneth W. Davidson Kenneth W. Davidson Chairman of the Board and Chief Executive Officer

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Encore Medical Corporation and furnished to the Securities and Exchange Commission or its staff upon request. The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this Report or as a separate disclosure document.

-36-